# Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

> **NCT06949956** · — · NOT_YET_RECRUITING · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 140 (estimated)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06949956
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06949956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06949956, "Administration of Fingolimod in Greek Patients With Multiple Sclerosis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06949956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*